Pages that link to "Q36441971"

The following pages link to Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer's Disease (Q36441971):

Displaying 25 items.

• Mitochondrial Dysfunction in Alzheimer's Disease and the Rationale for Bioenergetics Based Therapies (Q26750081) (← links)
• Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease (Q26801929) (← links)
• Mitochondrial oxidative stress in aging and healthspan (Q27025099) (← links)
• Mitochondria in Alzheimer's Disease and Diabetes-Associated Neurodegeneration: License to Heal! (Q33364882) (← links)
• New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders (Q33783000) (← links)
• Mitochondrial alterations near amyloid plaques in an Alzheimer's disease mouse model. (Q37251946) (← links)
• SS31 ameliorates age-related activation of NF-κB signaling in senile mice model, SAMP8 (Q37709206) (← links)
• Oxidant/Antioxidant imbalance and the risk of Alzheimer's disease (Q37741560) (← links)
• Alzheimer's Disease: From Mitochondrial Perturbations to Mitochondrial Medicine (Q38872085) (← links)
• Mitochondria as a target for neuroprotection: implications for Alzheimer´s disease (Q38883083) (← links)
• Antioxidative and antibacterial peptides derived from bovine milk proteins (Q38936638) (← links)
• Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease (Q38962796) (← links)
• Relationship Between β-Amyloid and Mitochondrial Dynamics (Q38986869) (← links)
• An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology. (Q39281122) (← links)
• Oxidative toxicity in diabetes and Alzheimer's disease: mechanisms behind ROS/ RNS generation. (Q41714460) (← links)
• The balance mediated by miRNAs and the heme oxygenase 1 feedback loop contributes to biological effects (Q44613878) (← links)
• Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer's disease. (Q48314660) (← links)
• Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer's Disease (Q48513067) (← links)
• An investigation into closed-loop treatment of neurological disorders based on sensing mitochondrial dysfunction (Q50032095) (← links)
• Mangiferin and Morin Attenuate Oxidative Stress, Mitochondrial Dysfunction, and Neurocytotoxicity, Induced by Amyloid Beta Oligomers. (Q55658793) (← links)
• Translating the biology of aging into novel therapeutics for Alzheimer disease (Q61450425) (← links)
• Mitochondria-Targeted Antioxidants as Potential Therapy for the Treatment of Traumatic Brain Injury. (Q64966686) (← links)
• Mitochondria Targeted Therapeutics for Alzheimer's Disease: The Good. The Bad. The Potential (Q90114589) (← links)
• Novel pharmacotherapy for burn wounds: what are the advancements (Q90275478) (← links)
• Mitochondria-Targeted Peptide SS31 Attenuates Renal Tubulointerstitial Injury via Inhibiting Mitochondrial Fission in Diabetic Mice (Q91690552) (← links)